COM:RELAYTX
Relay Therapeutics
- Stock
Last Close
3.96
14/02 21:00
Market Cap
927.87M
Beta: -
Volume Today
1.13M
Avg: -
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|---|
net income | -48.78M - | -75.31M 54.36% | -52.41M 30.40% | -363.87M 594.25% | -290.51M 20.16% | -341.97M 17.72% | |
depreciation and amortization | 2.15M - | 2.85M 32.08% | 3.55M 24.75% | 3.92M 10.59% | 4.13M 5.22% | 5.27M 27.58% | |
deferred income tax | 2.05M - | -10.76M - | |||||
stock based compensation | 2.89M - | 4.46M 54.35% | 31.96M 617.24% | 48.45M 51.61% | 56.14M 15.86% | 86.03M 53.25% | |
change in working capital | -400K - | 4.31M 1,177.50% | -85.17M 2,076.10% | 97.34M 214.29% | 11.25M 88.45% | -32.46M 388.62% | |
accounts receivables | -75M - | 74.68M 199.57% | 97K 99.87% | 306K 215.46% | |||
inventory | -10.33M - | 21.46M 307.72% | -31.88M - | ||||
accounts payables | 1.23M - | 3M 143.51% | -410K 113.67% | 930K 326.83% | 1.99M 113.87% | -2.39M 220.36% | |
other working capital | -1.63M - | 1.31M 180.27% | 571K 56.41% | 277K 51.49% | 9.16M 3,206.86% | 1.51M 83.53% | |
other non cash items | 9K - | -2.44M 27,200% | -416K 82.94% | 137.69M 33,198.80% | -10.49M 107.62% | -6.42M 38.81% | |
net cash provided by operating activities | -44.13M - | -66.13M 49.84% | -102.49M 54.97% | -74.41M 27.40% | -229.49M 208.43% | -300.32M 30.86% | |
investments in property plant and equipment | -1.69M - | -8.00M 374.33% | -1.93M 75.87% | -3.47M 79.75% | -9.06M 161.08% | -4.13M 54.47% | |
acquisitions net | 20K - | -83.60M 418,115.00% | -25.30M 69.74% | 179.68M 810.27% | -257.63M 243.38% | ||
purchases of investments | -553.52M - | -266.45M 51.86% | -980.66M 268.04% | -535.42M 45.40% | -385.54M 27.99% | ||
sales maturities of investments | 242.47M - | 350.06M 44.37% | 529.92M 51.38% | 355.74M 32.87% | 647.30M 81.96% | ||
other investing activites | 7K - | 83.60M - | -179.68M - | 257.63M 243.38% | |||
net cash used for investing activites | -1.68M - | -319.02M 18,889.52% | 81.67M 125.60% | -479.51M 687.12% | -188.75M 60.64% | 257.63M 236.50% | |
debt repayment | |||||||
common stock issued | 613K - | 427.80M 69,687.93% | 382.21M 10.66% | 284.74M 25.50% | 30.28M 89.37% | ||
common stock repurchased | |||||||
dividends paid | |||||||
other financing activites | 394.97M - | 4.99M 98.74% | -1.29M 125.86% | 5.88M 555.46% | 5.17M 12.14% | 4.47M 13.43% | |
net cash used provided by financing activities | 394.97M - | 5.61M 98.58% | 426.51M 7,508.08% | 388.09M 9.01% | 289.91M 25.30% | 34.75M 88.01% | |
effect of forex changes on cash | |||||||
net change in cash | 349.16M - | -379.55M 208.70% | 405.69M 206.89% | -165.83M 140.88% | -128.32M 22.62% | -7.93M 93.82% | |
cash at beginning of period | 73.23M - | 422.38M 476.82% | 42.83M 89.86% | 448.52M 947.17% | 282.70M 36.97% | 154.37M 45.39% | |
cash at end of period | 422.38M - | 42.83M 89.86% | 448.52M 947.17% | 282.70M 36.97% | 154.37M 45.39% | 146.44M 5.14% | |
operating cash flow | -44.13M - | -66.13M 49.84% | -102.49M 54.97% | -74.41M 27.40% | -229.49M 208.43% | -300.32M 30.86% | |
capital expenditure | -1.69M - | -8.00M 374.33% | -1.93M 75.87% | -3.47M 79.75% | -9.06M 161.08% | -4.13M 54.47% | |
free cash flow | -45.82M - | -74.14M 61.79% | -104.42M 40.85% | -77.88M 25.42% | -238.55M 206.32% | -304.44M 27.62% |
All numbers in USD (except ratios and percentages)